May 14, 2020 / 9:30 PM / 19 days ago

BRIEF-TFF Pharmaceuticals Posts Quarterly Loss Per Share $0.20

May 14 (Reuters) - TFF Pharmaceuticals Inc:

* TFF PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL AND BUSINESS RESULTS

* TFF PHARMACEUTICALS INC - MAINTAINS CLINICAL PROGRESS WITH LEAD PROGRAMS, VORICONAZOLE INHALATION POWDER AND TACROLIMUS INHALATION POWDER

* TFF PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.20 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below